# Observational Study of the Safety and Efficacy of Norditropin® in Adult Patients With Growth Hormone Deficiency

> **NCT01109017** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 387 (actual)

## Conditions studied

- Growth Hormone Disorder
- Adult Growth Hormone Deficiency

## Interventions

- **DRUG:** somatropin

## Key facts

- **NCT ID:** NCT01109017
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 387 (ACTUAL)
- **Last updated:** 2015-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01109017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01109017, "Observational Study of the Safety and Efficacy of Norditropin® in Adult Patients With Growth Hormone Deficiency". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01109017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*